Skip to content

Booster Dose of HCG for Unruptured Follicle in Non IVF/ICSI Cycles

Booster Dose of Human Chorionic Gonadotrophin for Unruptured Follicle in Non IVF/ICSI Cycles: A Randomized Controlled Study

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03580031
Enrollment
110
Registered
2018-07-09
Start date
2018-08-01
Completion date
2021-01-01
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

LUF - Luteinised Unruptured Follicle Syndrome

Keywords

LUF, HCG, Booster dose, Ovulation rate, pregnancy rate

Brief summary

This study will be conducted to assess the effect of booster dose of hCG on the unruptured follicles in non IVF/ICSI cycles.

Detailed description

In this study enrolled patients (n=160) who underwent controlled ovarian stimulation and timed intercourse with unruptured mature graffian follicle 48 hours after IM 10,000 IU HCG dose. Patients were allocated randomly into intervention group and control group. In the intervention group another booster dose (10,000 IU of hCG) was given IM while in the control group 2 ml normal saline was given IM leaving follicles for spontaneous rupture

Interventions

DRUGhCG

A booster dose (10,000 IU of hCG) was given IM 48 hours after first triggering dose

DRUGSaline Solution

2 ml of normal saline will be injected 48 hours after first triggering dose

Sponsors

Tanta University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Masking description

Double blinded

Intervention model description

Cohort groups with parallel allocation

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Ordinary stimulated cycles * IUI stimulated cycles * Unruptured follicle after 10000 IU IM HCG triggering

Exclusion criteria

* IVF/ICSI cycles

Design outcomes

Primary

MeasureTime frameDescription
Ovulation rate48 hoursrupture of dominant follicle manifested by disappearance of follicle and presence of free fluid in douglas pouch

Secondary

MeasureTime frameDescription
Pregnancy rate15 daysNumber of cases with positive serum pregnancy test

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026